DPHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Sep 2018

CCM DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2018
Quarter 3 Qtr
Quarterly report for the financial period ended 30 Sep 2018
The figures have not been audited

Attachments

CCMDBIO-Q3 2018 28112018.pdf
378.5 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2018

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Sep 2018
30 Sep 2017
30 Sep 2018
30 Sep 2017
$$'000
$$'000
$$'000
$$'000
1 Revenue
125,838
115,379
383,088
355,734
2 Profit/(loss) before tax
15,838
14,207
42,008
38,971
3 Profit/(loss) for the period
12,286
11,127
33,272
30,332
4 Profit/(loss) attributable to ordinary equity holders of the parent
12,286
11,127
33,272
30,332
5 Basic earnings/(loss) per share (Subunit)
1.86
1.75
5.09
4.70
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
1.50
1.07


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.7600
0.7400

Remarks :
Following the completion of the bonus issue on 20 June 2018, the following items have been retrospectively adjusted to reflect the effect of the bonus issue:

i)   Earnings Per Share for the corresponding quarter and year to date ended 30 September 2017;
ii)  Net Assets Per Share as at preceding financial year ended 31 December 2017; and
iii) Dividend Per Share for the corresponding year to date ended 30 September 2017.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name CCM DUOPHARMA BIOTECH BERHAD
Stock Name CCMDBIO
Date Announced 28 Nov 2018
Category Financial Results
Reference Number FRA-15112018-00004